Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis

Hepato-Gastroenterology

Volumn 54, Issue 79, 2007, Pages 2092-2098

  Zhang, Li Juan ^a   Zheng, Wei Da ^a   Chen, Yun Xin ^a   Huang, Yue Hong ^a   Chen, Zhi Xin ^a   Zhang, Sheng Jun ^a   Shi, Mei Na ^a   Wang, Xiao Zhong ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

SMA; Hepatic stellate cell; Interleukin 10; Liver fibrosis; MMP 2; NF B; Rat; TGF 1; TIMP 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DRUG EFFECT; FIBROGENESIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTINS; ANIMALS; DISEASE MODELS, ANIMAL; ELECTROPHORESIS; FIBRINOLYSIS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MATRIX METALLOPROTEINASE 2; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA1;

EID: 37749021405     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Friedman SL: Molecular mechanisms of hepatic fibrosis and principles of therapy. J Gastroenterol 1997; 32:424-430.
2. Du WD, Zhang YE, Zhai WR, Zhou XM: Dynamic changes of type I, III and IV collagen synthesis and distribution of collagen producing cells in carbon tetrachloride-induced rat liver fibrosis. World J Gastroenterol 1999; 5:397-403.
3. Wang JY, Guo JS, Yang CQ: Expression of exogenous rat collagenase in vitro and in a rat model of liver fibrosis. World J Gastroenterol 2002; 8:901-907.
4. Nakamura T, Sakata R, Ueno T, Sata M, Ueno H: Inhibition of transforming growth factor β prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine- treated rats. Hepatology 2000; 32:247-255.
5. Bissell DM, Roulot D, George J: Transforming growth factor β and the liver. Hepatology 2001; 34:859-867.
6. Safadi R, Friedman SL: Hepatic Fibrosis - Role of Hepatic Stellate Cell Activation. MedGenMedicine 2002; 4:27.
7. Rockey DC: The cell and molecular biology of hepatic fibrogenesis. Clinical and therapeutic implications. Clin Liver Dis 2000; 4:319-355.
8. McCrudden R, Iredale JP: Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases. Histol Histopathol 2000; 15:1159-1168.
9. Bataller R, Brenner DA: Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 2001; 21:437-451.
10. Knittel T, Kobold D, Piscaglia F, Saile B, Neubauer K, Mehde M, Timpl R, Ramadori G: Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers:distinct role of (myo-)fibroblast subpopulations in hepatic tissue repair. Histochem Cell Biol 1999; 112:387-401.
11. Hellerbrand, Wang SC, Tsukamoto H, Brenner DA, Rippe RA: Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology 1996; 24:670-676.
12. Neubauer K, Saile B, Ramadori G: Liver fibrosis and altered matrix synthesis. Can J Gastroenterol 2001; 15:187-193.
13. Benyon RC, Arthur MJ: Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 2001; 21:373-384.
14. Will H, Atkinson SJ, Butler GS, Smith B, Murphy G: The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 1996; 271:17119-17123.
15. Rippe RA: Life or death: the fate of the hepatic stellate cell following hepatic injury. Hepatology 1998; 27:1447-1448.
16. Dokka S, Shi X, Leonard S, Wang L, Castranova V, Rojanasakul Y: Interleukin-10-mediated inhibition of free radical generation in macrophages. Am J Physiol Lung Cell Mol Physiol 2001; 280:L1196-1202.
17. Nelson DR, Lauwers GY, Lau JY, Davis G: Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology 2000; 118:655-660.
18. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:431-435.
19. Ramm GA: Isolation and culture rat hepatic stellate cells. J Gastroenterol Hepatol 1998; 13:846-851.
20. Wang XZ Zhang SJ, Chen YX, Chen ZX, Huang YH, Zhang LJ: Effects of platelet-derived growth factor and interleukin-10 on Fas/Fas-ligand and Bcl-2/Bax mRNA expression in rat hepatic stellate cells in vitro. World J Gastroenterol 2004; 10:2706-2710.
21. Friedman SL: Cytokines and fibrogenesis. Semin Liver Dis 1999; 19:129-140.
22. Tsukamoto H, Matsuoka M, French SW: Experimental models of hepatic fibrosis: a review. Semin Liver Dis 1990; 10:56-65.
23. Nakamura T, Sakata R, Ueno T, Sata M, Ueno H: Inhibition of transforming growth factor β prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 2000; 32:247-255.
24. Dooley S, Delvoux B, Lahme B, Mangasser-Stephan K, Gressner AM: Modulation of transforming growth factor β response and signaling during transdifferentitation of rat hepatic stellate cells to myofibroblasts. Hepatology 2000; 31:1094-1106.
25. Garcia-Trevijano ER, Iraburu MJ, Fontana L, Dominguez-Rosales JA, Auster A, Covarrubias-Pinedo A, Rojkind M: Transforming growth factor b1 induces the expression of a1 (I) procollagen mRNA by a hydrogen peroxide-C/EBP β-dependent mechanism in rat heaptic stellate cells. Hepatology 1999; 29:960-970.
26. Si XH, Yang LJ: Extraction and purification of TGFβ and its effect on the induction of apoptosis of hepatocytes. World J Gastroenterol 2001; 7:527-531.
27. Nagase H, Woessner JF Jr: Matrix metalloproteinases. J Biol Chem 1999; 30:21491-21494.
28. Monea S, Lehti K, Keski-Oja J, Mignatti P: Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism. J Cell Physiol 2002; 192:160-170.
29. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP: Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997; 74:111-122.
30. Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJ: Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 1996; 110:821-831.
31. Iredale JP, Goddard S, Murphy G, Benyon RC, Arthur MJ: Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin Sci 1995; 89:75-81.
32. Sato M, Suzuki S, Senoo H: Hepatic stellate cells: unique characteristics in cell biology and phenotype. Cell Struct Funct 2003; 28:105-112.
33. Schwabe RF, Schnabl B, Kweon YO, Brenner DA: CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells. J Immunol 2001; 166:6812-6819.
34. 4-plus ethanol-induced liver cirrhosis in rats. Liver 1998; 18:180-185.
35. Iimuro Y, Nishiura T, Hellerbrand C, Behrns KE, Schoonhoven R, Grisham JW, Brenner DA: NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 1998; 101:802-811.
36. Oberholzer A, Oberholzer C, Moldawer LL: Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 2002; 30(1 Suppl):S58-63.
37. Wakkach A, Cottrez F, Groux H: Can interleukin-10 be used as a true immunoregulatory cytokine? Eur Cytokine Netw 2000; 11:153-160.
38. Groux H, Cottrez F: The complex role of interleukin-10 in autoimmunity. J Autoimmun 2003; 20:281-285.
39. Asadullah K, Sterry W, Volk HD: Interleukin-10 therapy-review of a new approach. Pharmacol Rev 2003; 55:241-269.
40. Wang XZ, Zhang LJ, Li D, Huang YH, Chen ZX, Li B: Effects of transmitters and interleukin-10 on rat hepatic fibrosis induced by CCl4. World J Gastroenterol 2003; 9:539-543.